Competitive Salary: EMBL: Group Leader – Computational Biology/Bioinformatics Germany (DE)

Funding Opportunity PAR-19-351 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Exploratory and Developmental Research Grant (R21) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R21 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R21 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application.

Educate and guide technicians and other researchers for accurate experimental design, data collection, analysis, time management, organization and optimization…
From Plenty - Mon, 19 Aug 2019 23:34:34 GMT - View all Laramie, WY jobs

Notice NOT-GM-19-058 from the NIH Guide for Grants and Contracts

Notice NOT-CA-19-067 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Clinical Bioinformatician London To build on the success of the 100,000 Genomes Project, the Government tasked NHS England with support from Genomics London, England

Negotiable: Paramount Recruitment: The Director of Bioinformatics will be involved with developing departmental strategy focussing on target identification, biomarkers, target validation and qualification of drug targets, focussing predominantly on cardio-metabolic diseases. Oxford, England

Notice NOT-NS-20-001 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-003 from the NIH Guide for Grants and Contracts

Notice NOT-DK-19-018 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-004 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-349 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research. The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA. It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.

Funding Opportunity PAR-19-346 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.

Funding Opportunity PAR-19-347 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.

Funding Opportunity PAR-19-345 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) announces the availability of support for collaborative research by multi-disciplinary teams which is of high priority to NIDA and leads to synergistic outcomes based on the synthesis of multiple research approaches. The NIDA Program Projects funding opportunity will support research in which the funding of three or more highly meritorious projects as a group enriches both the component projects and the overall program to offer significant scientific advantages over supporting the same projects as individual research grants (i.e., synergy). For the duration of the award, each Program must consist of a minimum of three research projects focused on issues critical to advance the mission and goals of NIDA.

Notice NOT-AI-19-066 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-348 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.

Funding Opportunity PAR-19-350 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication pilot interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.

Isolation and analysis of tumor infiltrating lymphocytes using multiplex single-cell analysis techniques. Perform manual or computer-assisted data analysis,…
From West Virginia University - Thu, 15 Aug 2019 22:05:54 GMT - View all Morgantown, WV jobs

F. Hoffmann-La Roche AG: Roche has been taken a strategic effort across functions and sites to improve data quality and to make data FAIR (findable, accessible, interop Switzerland (CH)